Treatment of dairy buffaloes naturally infected with sarcoptic mange.

Therapeutic trials of sarcoptic mange in buffaloes were studied at local Livestock farms, Lahore (Pakistan). A total of 600 buffaloes were examined over 1 year period (August 2006 to July 2007) for prevalence study, while 60 buffaloes were selected for therapeutic trial. Sarcoptic mange was recorded in 66 (11%) animals. The highest monthly prevalence was reported during the months of January and February (18%) followed by December and March (16%) whereas lowest during the month of July (2%). Over all highest seasonally prevalence was recorded during winter (16.5%) and lowest during summer (5%). Moreover, highest infestation rate was recorded among young (<3 months) buffaloes than with age >3 months. Sex-wise prevalence indicated more prevalence in buffalo bulls (13.15%) than female buffaloes (9.28%). Therapeutic trials were carried out by using ivermectin, doramectin and trichlorphon as per manufacturer's recommendations for a period of 10 days, while one group was kept as untreated control. Negative skin scraping, disappearance of gross lesions, stoppage of itching and regrowth of normal hair were taken as the criterion to assess the efficacy of these drugs.